Connect Sign InAACC 2019 Booth Presentation: Harnessing the Power of Pharm/Lab Collaboration
Whether intentionally or incidentally, the lab and pharmacy departments interact on a daily basis. But what does that look like, and how do we turn toward more intentional collaboration? The key is to identify where these interactions take place. Dr. Kauffman will discuss how emerging, high profile initiatives (e.g., precision medicine) depend heavily upon teamwork and leadership from both the lab and pharmacy departments for better patient outcomes.
Dr. Kauffman received undergraduate degrees in computer information systems and business administration, her MBA from Rensselaer Polytechnic Institute, and her PharmD from The State University of New York at Buffalo. She is a member of the American Society of Health-System Pharmacists (ASHP) and Healthcare Information and Management Systems Society (HIMSS). She has the Apexus Advanced 340B Certificate and completed certification in clinical applications of pharmacogenomics at the University of Florida. Dr. Kauffman’s primary area of focus is pharmacogenomics and the ways in which appropriate laboratory testing can positively influence therapeutic drug monitoring (TDM). Other research interests include population health, opioid and antibiotic stewardship, and the effect of lab/pharmacy collaboration on service line workflows.
